Literature DB >> 12379353

Reactive immunization: a unique approach to catalytic antibodies.

Fujie Tanaka1, Carlos F Barbas.   

Abstract

The development of antibody catalysts and indeed natural antibody responses has in the past been based on non-covalent binding to antigens. In contrast to this, reactive immunization utilizes reactive immunogens that covalently react with antibodies during the course of their induction through a designed chemical transformation. The inducing chemical transformation is designed to become part of the catalytic mechanism when the antibody is subsequently challenged with substrate molecules. Reactive immunization has proven to be an efficient approach to generating highly proficient catalytic antibodies with unusually broad substrate scope. This review describes catalytic antibodies generated by reactive immunization, their features and applications, as well as in vitro selection of catalytic antibodies based on reactive compounds.

Mesh:

Substances:

Year:  2002        PMID: 12379353     DOI: 10.1016/s0022-1759(02)00225-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst.

Authors:  Christoph Rader; Subhash C Sinha; Mikhail Popkov; Richard A Lerner; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

2.  Expanding the concept of chemically programmable antibodies to RNA aptamers: chemically programmed biotherapeutics.

Authors:  Ulrich Wuellner; Julia I Gavrilyuk; Carlos F Barbas
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-09       Impact factor: 15.336

Review 3.  Chemically programmed antibodies.

Authors:  Christoph Rader
Journal:  Trends Biotechnol       Date:  2014-03-11       Impact factor: 19.536

4.  N-Sulfonyl-β-lactam hapten as an effective labeling reagent for aldolase mAb.

Authors:  Tsubasa Inokuma; Roberta P Fuller; Carlos F Barbas
Journal:  Bioorg Med Chem Lett       Date:  2015-03-10       Impact factor: 2.823

Review 5.  Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.

Authors:  Patrick J McEnaney; Christopher G Parker; Andrew X Zhang; David A Spiegel
Journal:  ACS Chem Biol       Date:  2012-07-03       Impact factor: 5.100

6.  Direct observation of an enamine intermediate in amine catalysis.

Authors:  Xueyong Zhu; Fujie Tanaka; Richard A Lerner; Carlos F Barbas; Ian A Wilson
Journal:  J Am Chem Soc       Date:  2009-12-30       Impact factor: 15.419

7.  Asymmetric approach toward chiral cyclohex-2-enones from anisoles via an enantioselective isomerization by a new chiral diamine catalyst.

Authors:  Jung Hwa Lee; Li Deng
Journal:  J Am Chem Soc       Date:  2012-10-22       Impact factor: 15.419

8.  An Engineered Arginine Residue of Unusual pH-Sensitive Reactivity Facilitates Site-Selective Antibody Conjugation.

Authors:  Napon Nilchan; James M Alburger; William R Roush; Christoph Rader
Journal:  Biochemistry       Date:  2021-03-23       Impact factor: 3.162

Review 9.  Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans.

Authors:  Anna S Tolmacheva; Georgy A Nevinsky
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

10.  Crystal structure of two anti-porphyrin antibodies with peroxidase activity.

Authors:  Victor Muñoz Robles; Jean-Didier Maréchal; Amel Bahloul; Marie-Agnès Sari; Jean-Pierre Mahy; Béatrice Golinelli-Pimpaneau
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.